505
Participants
Start Date
November 30, 2003
Primary Completion Date
July 31, 2008
Study Completion Date
July 31, 2008
exenatide
subcutaneous injection, twice daily; 5 mcg for 4 weeks followed by 10 mcg for 48 weeks
biphasic insulin aspart
subcutaneous injection, twice daily; titration to target blood glucose level
Veteran General Hospital-Taichung, Taichung
Changhua Christian Hospital, Changhua
Univerzitetni klinicni center Ljubljana, Ljubljana
Splosna bolnisnica Maribor, Maribor
Klinica bolnica Dubrava, Zagreb
Klinicki bolnicki centar Zagreb-Rebro, Zagreb
"Opca bolnica Sveti Duh", Zagreb
"Polyclinic General Hospital of Athens", Athens
Department of Endocrinology, Athens
Diabetes Center, Athens
Diabetologische Schwerpunktpraxis, Hamburg
University Hospital of Patras, Pátrai
Clinical Hospital Osijek, Osijek
Ospedale Civile di Padova, Padua
Medical Clinic and Policlinic 3, Giessen
Hospital Virgen de Valme, Seville
Profil, Institut fur Stoffwechselstorungen, Neuss
Hospital General de Teruel, Teruel
Dr. Klaus Busch, Dortmund
Marienhospital Osnabruck, Osnabrück
Dipartimento di fisiopatologia clinica, Florence
IKFE GmbH, Mainz
"1st Internal Medicine Department Papagergiou", Thessaloniki
Dr. Thomas Behnke, Neuwied
Dr. Karlheinz Hehemann, Beckum
Dr. Jerzi Jasinski, Wiesbaden
Institut for diabetic research, Munich
Internistische Gemeinschaftspraxis, Augsburg
Policlinico Univarsitario P. Giaccone, Palermo
Instituto di Endocrinologia, Catania
National Endocrinology Research Center, Moscow
Setchenov Moscow Medical Academy, Moscow
Moscow State Medical Stomatological, Moscow
Russian Medical Academy for Advanced Medical Studies, Ministry of Health, Moscow
Hospital of St. Elizabeth's, Saint Petersburg
City Clinical Hospital #2, Saint Petersburg
Medical Military Academy, Saint Petersburg
Spitalul Clinic nr. 1 Judetean, Judet Timis
Spitalul Judetean Brasov, Brasov
Dr. Bernd Donaubauer, Oschatz
Dr. Joerg Steindorf, Schkeuditz
U.O. Medicina Generale, Milan
U.O. Universita di Malattie del Metabolismo e Diabetologia, Torino
Tzu Chi General Hospital, Hualien City
Tri-Service General Hospital, Taipei
Gelre Ziekenhuizen, Apeldoorn
Rijnstate Ziekenhuis, Arnhem
Maxima Medisch Centrum Location Eindhoven, Eindhoven
Hospitais da Universidade de Coimbra, Coimbra
Hospital de Santo Andre, Leiria
Associacao Protectora dos Diabeticos de Portugal, Lisbon
Hospital Pedro Hispano, Matosinhos Municipality
Institutul de Diabet, Bucharest
Hospital Vega Baja, Alicante
Hospital Clinic i Provincial de Barcelona, Barcelona
Endocrinology Service (Planta Baja), Palma de Mallorca
Hospital la Ribera Alzira, Valencia
Diabetes Research, Ward 34, Birmingham Heartlands Hospital, Birmingham
Diabetes Unit, Blackburn Royal Infirmary, Blackburn
Colchester General Hospital, Colchester
Royal Infirmary of Edinburgh, Edinburgh
Glasgow Royal Infirmary, Glasgow
The Michael White Center for Diabetes and Endocrinology, Hull
Clinical Sciences Centre, Liverpool
Education Centre, James Cook University Hospital, Middlesbrough
Wellcome Labs, Royal Victoria Infirmary, Newcastle upon Tyne
Queens Medical Centre, Nottingham
Diabetes Trial Unit OCDEM, Churchill Hospital, Oxford
Diabetes Unit, Gladsone Centre, Maelor Hospital, Wrexham
Lead Sponsor
Eli Lilly and Company
INDUSTRY
AstraZeneca
INDUSTRY